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Major role for PKCα in inside-out regulation of αIIbβ3 but no significant role 








































PKCα plays a major role in regulating 
inside-out signaling to integrin αIIbβ3 
but no significant role in outside-in sig-
naling or in adhesion to fibrinogen or 
collagen. (A) Washed platelets from 
WT or Prkca–/– mice were labeled with 
PE–anti-αIIbβ3 antibody and stimulated 
with CRP (5 μg/ml) or thrombin (1 U/ml) 
for 15 minutes; immunofluorescence 
intensity was measured by flow cytom-
etry. The data presented are geometric 
means as percentages of basal non-
stimulated levels. Error bars represent 
SEM. n = 3. *P < 0.05. (B–D) Washed 
platelets from WT or Prkca–/– mice were 
added to CRP- or fibrinogen-coated 
coverslips, and the levels of spread-
ing and adherence were analyzed. 
(B) Representative images of murine 
platelets 40 minutes after addition to 
CRP- or fibrinogen-coated surfaces as 
indicated. Images were taken under 
oil immersion. Original magnification, 
×63. Scale bars: 5 μm. (C and D) Time 
course of WT and Prkca–/– platelet 
adherence (number of platelets esti-
mated per field of view; upper panel) 
and spreading (as assessed by mea-
surement of cell surface area; lower 
panel) on CRP-coated (C) and fibrino-
gen-coated (D) surfaces. Data shown 
are mean ± SEM. n = 4.
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compared with 62.18 ± 5.6 platelets/field of view in Prkca–/– mice; 
mean ± SEM, P < 0.05) in platelets adherent to fibrinogen.




















































Key role for PKCα in secretion of dense granules and α-granules. (A) 
Washed platelets from WT or Prkca–/– mice were stimulated with CRP 
(5 μg/ml) or thrombin (0.25 U/ml) and secretion of ATP assessed by 
luminometry. Data shown represent maximal increase in ATP concen-
tration and represent mean ± SEM. n = 3. *P < 0.05. (B) Platelets from 
WT or Prkca–/–mice were labeled with FITC-C62P antibody and stimu-
lated with CRP (5 μg/ml) or thrombin (1 U/ml) for 15 minutes. Fluo-
rescence intensity was measured by flow cytometry. Data presented 
represent geometric means as percentages of basal nonstimulated 
levels. Error bars represent SEM. n = 3.
Figure 3
PKCα regulates dense-granule but not α-granule biogenesis. Washed 
platelets from WT or Prkca–/– mice were examined by transmission 
electron microscopy, and the number of dense granules (black arrows) 
and α-granules (white arrows) was quantified as described in Methods. 
(A) Images of WT (left panel) or Prkca–/– (right panel) platelets are rep-
resentative of 3 independent experiments. Scale bar: 1 μm. Original 
magnification, ×19,000. (B) Dense granules (left panel) and α-granules 
(right panel) were counted per field of view (25–30 fields of view per 
preparation) and shown as mean ± SEM for number of granules per 
μm2. n = 3. *P < 0.05.
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Pharmacological inhibition of PKCβ reveals redundancy with PKCα for 




















(0.5  U/ml),  for  which  addition  of  10  μM 
LY333531  had  no  effect  upon WT platelet 
aggregation response but markedly inhibited 






























ADP rescues deficient aggregation 
responses to CRP or thrombin in Prkca–/– 
platelets. Washed platelets from WT or 
Prkca–/– mice were stimulated with vari-
ous concentrations of CRP (A) or throm-
bin (B) with or without simultaneous 
addition of ADP (10 μM) and aggrega-
tion assessed turbidimetrically. Aggre-
gation traces shown are representative 
of 4 independent experiments.
Figure 5
Combined pharmacological and genetic approaches reveal redundancy between PKCα and 
PKCβ for regulation of platelet aggregation. (A and B) Washed platelets from WT or Prkca–/– 
mice were pretreated (10 minutes) with the classical PKC isoform inhibitor Gö6976 (1 μM) 
(A), the PKCβ-selective inhibitor LY333531 (10 μM) (B), or DMSO as vehicle control and 
stimulated with CRP (5 μg/ml). Aggregation was monitored by turbidimetric aggregometry. 
Traces shown are representative of 5 independent experiments. (C) Washed platelets from 
WT or Prkca–/– mice were stimulated with U46619 (U4) (10 μM) and aggregation assessed 
turbidimetrically. Traces shown are representative of 4 independent experiments.
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anticoagulated) blood from WT or 
Prkca–/– mice was passed over col-
lagen (shear rate 1000 s–1). (A and 
B) ADP solution was coinfused at a 
10% flow rate (20 μM ADP, final con-
centration) (lower panels). (A) Rep-
resentative phase-contrast images 
after 4 minutes. Images were taken 
under oil immersion. Scale bars: 20 
μm. Original magnification, ×63. (B) 
Surface area coverage with thrombi. 
Mean ± SEM. n ≥ 3.*P < 0.0001.
Figure 7
In vivo thrombus formation is impaired in the absence of PKCα, but tail bleeding time is normal. (A–D) Mice were either Prkca–/– or littermate-
matched wild-type controls. Platelets were labeled in vivo with Alexa Fluor 488, as described in Methods. (A) Platelets (green) composited with 
bright field images (black/white) of the cremaster arteriole were viewed, and images were acquired using a digital CCD camera (SensiCam II; 
Cooke Corp.) with a 640 × 480 pixel array. Original magnification, ×40. (B) Traces shown are median integrated platelet fluorescence of 15 
thrombi induced in 3 or more mice for each group. Fluorescent intensity of platelets in arbitrary units is presented as a function of time. (C) Data 
are presented as a scatter diagram. Horizontal bar represents mean of 15 thrombi induced in at least 3 mice for each group. There is a signifi-
cant reduction in thrombus intensity in Prkca–/– in comparison with WT controls (mean Prkca+/+, 652200; mean Prkca–/–, 279600; P < 0.05). (D) 
Time to reach peak thrombus size also significantly differed from WT controls, with mean data shown by the horizontal bars (mean Prkca+/+, 
68.1 seconds; mean Prkca–/–, 115.2 seconds; P < 0.01). (E) Mice were anesthetized and a transverse incision made with a scalpel at a position 
where the diameter of the tail was 2.25 to 2.5 mm. The tail was immersed in normal saline (37°C) in a hand-held test tube. The time from incision 
to cessation of bleeding was recorded, and mean times are shown as horizontal bars. No significant difference was seen comparing WT mice 
(mean 140 seconds) with Prkca–/– (mean 117 seconds; P > 0.05).
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Platelet spreading and adhesion assay. Coverslips were coated with either 
0.1 mg/ml fibrinogen or 50 μg/ml CRP and left overnight, followed by 
research article





























































































































  3. Shattil,  S.J.,  and Brass,  L.F.  1987.  Induction  of 
the  fibrinogen  receptor  on  human platelets  by 
intracellular mediators. J. Biol. Chem. 262:992–1000.














































  15. Pula,  G.,  et  al.  2006.  PKCδ  regulates  collagen-
induced platelet aggregation through inhibition 
of  VASP-mediated  filopodia  formation. Blood. 
108:4035–4044.
  16. Crosby, D., and Poole, A.W. 2003. Physical and 






core granule secretion  in platelets.  J. Biol. Chem. 
276:39379–39385.
  18. Tabuchi,  A.,  et  al.  2003.  Direct  demonstra-
tion of involvement of protein kinase Cα in the 




































Curr. Cancer Drug Targets. 4:327–336.
 29. Pfeifhofer, C.,  et  al.  2006. Defective  IgG2a/2b 


































































for platelet ADP  receptor  function  in dynamic 
thrombus stabilization. Blood. 108:3045–3052.
  49. Remijn,  J.A.,  et al. 2002. Role of ADP Receptor 
P2Y12 in platelet adhesion and thrombus forma-































integrin activation. Arterioscler. Thromb. Vasc. Biol. 
27:2484–2490.
